MARA Holdings, Inc. current report, 27 January 2017

Business Context and Reporting Period

This Form 8-K was filed by Marathon Patent Group, Inc. on January 27, 2017. The report discloses the entry into a material definitive agreement regarding the potential sale of common stock. Note: The input metadata references "MARA Holdings, Inc.", but the filing text explicitly identifies the registrant as "Marathon Patent Group, Inc."

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the terms of a new sales agreement rather than periodic financial performance.

Material Changes and Agreements

  • Sales Agreement: On January 27, 2017, the Company entered into an "at-the-market" sales agreement with Northland Securities, Inc.
  • Share Offering: The Company may offer and sell up to 750,000 shares of common stock through Northland.
  • Sale Method: Shares may be sold on the NASDAQ Capital Market, other trading markets, or via negotiated transactions. The Company retains the right to instruct Northland not to sell shares below a designated price.
  • Compensation: Northland will receive a commission of 3.0% of the aggregate gross proceeds from each sale.
  • Termination: The agreement terminates upon the sale of all shares or earlier termination by either party.

Guidance, Outlook, and Risks

The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard securities law disclaimers. The Company is not obligated to sell any shares under the agreement. The report includes a standard disclaimer that it does not constitute an offer to sell securities in any state where such an offer would be unlawful.

Key Facts for Investor Verification

  • Verify the current share count and the potential dilution impact of selling up to 750,000 shares.
  • Confirm the current market price of the stock to assess the potential proceeds and the 3.0% commission cost.
  • Review the full text of the Sales Agreement (Exhibit 10.1) for specific termination rights and price designation mechanisms.
  • Check subsequent filings to determine if any shares have actually been sold under this agreement.